These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33006019)

  • 1. Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activities.
    Pérez Sáez JM; Hockl PF; Cagnoni AJ; Méndez Huergo SP; García PA; Gatto SG; Cerliani JP; Croci DO; Rabinovich GA
    Angiogenesis; 2021 Feb; 24(1):1-5. PubMed ID: 33006019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma.
    Croci DO; Salatino M; Rubinstein N; Cerliani JP; Cavallin LE; Leung HJ; Ouyang J; Ilarregui JM; Toscano MA; Domaica CI; Croci MC; Shipp MA; Mesri EA; Albini A; Rabinovich GA
    J Exp Med; 2012 Oct; 209(11):1985-2000. PubMed ID: 23027923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8.
    Delgado VM; Nugnes LG; Colombo LL; Troncoso MF; Fernández MM; Malchiodi EL; Frahm I; Croci DO; Compagno D; Rabinovich GA; Wolfenstein-Todel C; Elola MT
    FASEB J; 2011 Jan; 25(1):242-54. PubMed ID: 20876211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potent anti-HB-EGF monoclonal antibody inhibits cancer cell proliferation and multiple angiogenic activities of HB-EGF.
    Sato S; Drake AW; Tsuji I; Fan J
    PLoS One; 2012; 7(12):e51964. PubMed ID: 23251664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death.
    Yang R; Sun L; Li CF; Wang YH; Xia W; Liu B; Chu YY; Bover L; Vien L; Hung MC
    J Biol Chem; 2022 Apr; 298(4):101821. PubMed ID: 35283189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of neutralizing antibodies reacting with the 213-224 amino-acid segment of human galectin-9.
    Lhuillier C; Barjon C; Baloche V; Niki T; Gelin A; Mustapha R; Claër L; Hoos S; Chiba Y; Ueno M; Hirashima M; Wei M; Morales O; Raynal B; Delhem N; Dellis O; Busson P
    PLoS One; 2018; 13(9):e0202512. PubMed ID: 30204750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different angioregulatory activity of monovalent galectin-9 isoforms.
    Aanhane E; Schulkens IA; Heusschen R; Castricum K; Leffler H; Griffioen AW; Thijssen VL
    Angiogenesis; 2018 Aug; 21(3):545-555. PubMed ID: 29500586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of immunomodulatory galectin-1 in peripheral leukocytes and adult tissues and its cytosolic organization in striated muscle.
    Dias-Baruffi M; Stowell SR; Song SC; Arthur CM; Cho M; Rodrigues LC; Montes MA; Rossi MA; James JA; McEver RP; Cummings RD
    Glycobiology; 2010 May; 20(5):507-20. PubMed ID: 20053628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-8 Favors VEGF-Induced Angiogenesis:
    Varinská L; Fáber L; Petrovová E; Balážová L; Ivančová E; Kolář M; Gál P
    Anticancer Res; 2020 Jun; 40(6):3191-3201. PubMed ID: 32487613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings.
    de Aguiar RB; Parise CB; Souza CR; Braggion C; Quintilio W; Moro AM; Navarro Marques FL; Buchpiguel CA; Chammas R; de Moraes JZ
    Cancer Lett; 2016 Feb; 371(2):151-60. PubMed ID: 26655277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of a monoclonal antibody that binds to Galectin-1.
    Pfeffer K; Ho TH; Grill FJ; Ruiz Y; Lake DF
    Protein Expr Purif; 2023 Oct; 210():106308. PubMed ID: 37209931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors.
    Etulain J; Negrotto S; Tribulatti MV; Croci DO; Carabelli J; Campetella O; Rabinovich GA; Schattner M
    PLoS One; 2014; 9(4):e96402. PubMed ID: 24788652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.
    Laderach DJ; Gentilini LD; Giribaldi L; Delgado VC; Nugnes L; Croci DO; Al Nakouzi N; Sacca P; Casas G; Mazza O; Shipp MA; Vazquez E; Chauchereau A; Kutok JL; Rodig SJ; Elola MT; Compagno D; Rabinovich GA
    Cancer Res; 2013 Jan; 73(1):86-96. PubMed ID: 23108139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial LGALS9 splice variant expression in endothelial cell biology and angiogenesis.
    Heusschen R; Schulkens IA; van Beijnum J; Griffioen AW; Thijssen VL
    Biochim Biophys Acta; 2014 Feb; 1842(2):284-92. PubMed ID: 24333696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation.
    Cedeno-Laurent F; Barthel SR; Opperman MJ; Lee DM; Clark RA; Dimitroff CJ
    J Immunol; 2010 Oct; 185(8):4659-72. PubMed ID: 20844192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
    Lai YD; Wu YY; Tsai YJ; Tsai YS; Lin YY; Lai SL; Huang CY; Lok YY; Hu CY; Lai JS
    Int J Mol Sci; 2016 Feb; 17(2):214. PubMed ID: 26861297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cells secrete galectin-1 to enhance endothelial cell activity.
    Thijssen VL; Barkan B; Shoji H; Aries IM; Mathieu V; Deltour L; Hackeng TM; Kiss R; Kloog Y; Poirier F; Griffioen AW
    Cancer Res; 2010 Aug; 70(15):6216-24. PubMed ID: 20647324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling.
    Wesley UV; Vemuganti R; Ayvaci ER; Dempsey RJ
    Brain Res; 2013 Feb; 1496():1-9. PubMed ID: 23246924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase.
    Fuertes MB; Molinero LL; Toscano MA; Ilarregui JM; Rubinstein N; Fainboim L; Zwirner NW; Rabinovich GA
    Mol Cell Biochem; 2004 Dec; 267(1-2):177-85. PubMed ID: 15663199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Anti-VEGF and Anti-CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes.
    Wu X; Li J; Connolly EM; Liao X; Ouyang J; Giobbie-Hurder A; Lawrence D; McDermott D; Murphy G; Zhou J; Piesche M; Dranoff G; Rodig S; Shipp M; Hodi FS
    Cancer Immunol Res; 2017 Jun; 5(6):446-454. PubMed ID: 28473314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.